5 Matching Annotations
  1. Oct 2026
    1. Case 2

      Case#: 13 yo, Female

      DiseaseAssertion: GT

      FamilyInfo:

      CasePresentingHPOs: (HP:0002249) Melena; (HP:0002248) Hematemesis

      PlateletAggregation: Prothrombin time: 20, Partial thromboplastin time: 28, Platelet function analyzer-100: >300

      CaseHPOFreeText: gastric and jejunum angiodysplasia

      ProteinExpression: Flow cytometry: CD41 and 61 <50%

      CasePreviousTesting: Molecular sequencing, Patients’ information was obtained from the medical record system of the Madinah Hereditary Blood Disorders Center, Maternity and Children Hospital, King Fahd Hospital, Al Madinah, Saudi Arabia.

      Gene: ITGB3

      HGVS: NM_000212.3:c.2111_2112del

      ClinVar:

      CAID: CA3062865178

      gnomAD:

    1. Our patient

      Case#: 4 mo, Female

      DiseaseAssertion: GT

      CasePresentingHPOs: (HP:0001892) Abnormal bleeding; (HP:0000978) Bruising susceptibility

      PlateletAggregation: Severe platelet refractoriness. Pretransplant evaluation revealed normal platelet count. Day +9, the patient had undetectable platelet count. Bleeding-control strategies included the use of thrombopoietin receptor agonist, romiplostim, and low-rate continuous platelet transfusion. Imlifidase was well tolerated with no side effects.

      CaseHPOFreeText: Escherichia coli bacteremia.

      ProteinExpression: Platelet GP expression testing confirmed the absence of platelet GPIIb/IIIa expression. Day +12 confirmed the presence of anti-GPIIb/IIIa antibodies among others.

      Gene: ITGB3

      HGVS: NM_000212.3:c.1788del

      ClinVar:

      CAID: CA2262611500

      gnomAD: 0 https://gnomad.broadinstitute.org/variant/chr17-47299404-GC-G?dataset=gnomad_r4

    1. Case 2

      Case#: Case 2, 20 yo Female

      DiseaseAssertion: Glanzman thrombasthenia

      ParentalGenotype: Not provided

      CasePresentingHPOs: (HP:0000978, Bruising susceptibility) (HP:0000421, Epistaxis)

      PlateletAggregation: Strong reduction of platelet aggregation with all agonists, except ristocetin. Normal platelet count.

      CaseHPOFreeText:

      CaseNotHPOs:

      CaseNotHPOFreeText:

      ProteinExpression: Flow cytometry, platelets with 18% to 24% residual αIIbβ3

      CasePreviousTesting: Not provided

      PreviouslyPublished: Not provided

      Gene: ITGB3

      HGVS: NM_000212.3:c.187C>T

      ClinVar: 631774 https://www.ncbi.nlm.nih.gov/clinvar/variation/631774/

      CAID: CA8622892

      gnomAD: PopMax = 0.00002555 https://gnomad.broadinstitute.org/variant/17-47283375-C-T?dataset=gnomad_r4

      Gene: ITGB3

      HGVS: NM_000212.3:c.505C>T

      ClinVar: 953061 https://www.ncbi.nlm.nih.gov/clinvar/variation/953061/

      CAID: CA291224658

      gnomAD: PopMax = 2.800e-7 https://gnomad.broadinstitute.org/variant/17-47284586-C-T?dataset=gnomad_r4

    1. patient 8

      Case#: Patient 8

      DiseaseAssertion: Glanzmann thrombasthenia

      FamilyInfo: Not provided

      ParentalGenotype: Not provided

      CasePresentingHPOs: (HP:0000421, Epistaxis)

      PlateletAggregation: All patients had abnormal platelet aggregation studies prompting analysis of platelet glycoprotein expression by flow cytometry.

      ProteinExpression: Flow cytometry, 11 of 12 patients with GT had reduced antibody binding to GPIIb/IIIa

      CasePreviousTesting: Not provided

      PreviouslyPublished: Not provided

      Gene: ITGA2B

      Variant: c.1750C>T, p. (R584X)

      HGVS: NM_000419.5:c.1750C>T

      ClinVar: 2892 https://www.ncbi.nlm.nih.gov/clinvar/variation/2892/

      CAID: CA115834

      gnomAD: PopMax = 0.00008834 https://gnomad.broadinstitute.org/variant/17-44380004-G-A?dataset=gnomad_r4

      Variant: c.2671C>T, p. (Q891X)

      HGVS: NM_000419.5:c.2671C>T

      ClinVar: 953054 https://www.ncbi.nlm.nih.gov/clinvar/variation/953054/

      CAID: CA8602626

      gnomAD: PopMax = 0.000007390 https://gnomad.broadinstitute.org/variant/17-44375647-G-A?dataset=gnomad_r4

    1. female infant

      Case#: Female, at birth

      DiseaseAssertion: Glanzmann Thrombasthenia

      FamilyInfo: Figure 1 Consanguinity Mother: 27 yo. Positive for mutation. Epistaxis, hypochromic microcytic anemia, cesarean postoperative vaginal bleeding. Maternal aunt present with GT, Positive for mutation. Maternal cousin present with GT, Positive for mutation. Paternal cousins present with GT, Positive for mutation.

      ParentalGenotype: Both parents heterozygous carriers.

      CasePresentingHPOs: HP:0000978, Bruising susceptibility. HP:0000225, Gingival bleeding. HP:0003265, Neonatal hyperbilirubinemia. HP:0011869, Abnormal platelet function. HP:0004887, Respiratory failure requiring assisted ventilation. HP:0000967, Petechiae.

      PlateletAggregation: Normal coagulation. Reduced platelet function.

      CaseHPOFreeText: APGAR score 9. Spontaneous skin bruising. Started on feeds second day of life.

      ProteinExpression: Platelet function assays showed severely reduced activity.

      Gene: ITGB3

      Variant: p.Asp145Asn

      HGVS: NP_000203.2:p.Asp145Asn

      ClinVar: 627066

      CAID: CA400021939

      gnomAD: Absent